The Costly Influence of Big Pharma on Healthcare

This chapter examines the troubling behaviors of pharmaceutical companies, emphasizing their focus on prolonging drug patents over enhancing healthcare. It discusses the high costs of treatments and the lobbying efforts that maintain these patents, while also addressing potential resistance to reform within the industry.